Literature DB >> 108106

Sanfilippo type C disease: clinical findings in four patients with a new variant of mucopolysaccharidosis III.

C Bartsocas, H Gröbe, J J van de Kamp, K von Figura, H Kresse, U Klein, M A Giesberts.   

Abstract

A new genetic variant of the Sanfilippo syndrome due to deficiency of acetyl CoA: alpha-glucosaminide N-acetyltransferase, was recently demonstrated in four patients. The clinical findings of these patients are reported here. Differential diagnosis from other types of the Sanfilippo syndrome on clinical and routine laboratory criteria is difficult and enzyme assay is necessary to reach the diagnosis. Since two of the patients reported are females and consanguinity was present in one case, autosomal recessive inheritance is most probable.

Entities:  

Mesh:

Year:  1979        PMID: 108106     DOI: 10.1007/bf00441361

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts.

Authors:  J C Fratantoni; C W Hall; E F Neufeld
Journal:  Science       Date:  1968-11-01       Impact factor: 47.728

2.  The defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide.

Authors:  J C Fratantoni; C W Hall; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1968-06       Impact factor: 11.205

3.  The sanfilippo B corrective factor: a N-acetyl-alpha-D-glucosamindiase.

Authors:  K von Figura; H Kresse
Journal:  Biochem Biophys Res Commun       Date:  1972-07-25       Impact factor: 3.575

4.  The Sanfilippo A corrective factor. Purification and mode of action.

Authors:  H Kresse; E F Neufeld
Journal:  J Biol Chem       Date:  1972-04-10       Impact factor: 5.157

5.  Biochemical heterogeneity of the Sanfilippo syndrome: preliminary characterization of two deficient factors.

Authors:  H Kresse; U Wiesmann; M Cantz; C W Hall; E F Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1971-03-05       Impact factor: 3.575

6.  Clinical variability in Sanfilippo B disease: a report on six patients in two related sibships.

Authors:  J J van de Kamp; J F van Pelt; K O Liem; M A Giesberts; L T Niepoth; C R Staalman
Journal:  Clin Genet       Date:  1976-11       Impact factor: 4.438

7.  Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.

Authors:  U Klein; H Kresse; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Human alpha-n-acetylglucosaminidase. 2. Activity towards natural substrates and multiple recognition forms.

Authors:  K von Figura
Journal:  Eur J Biochem       Date:  1977-11-01

9.  Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients.

Authors:  J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

10.  A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients.

Authors:  H Kresse; K Von Figura; U Klein
Journal:  Eur J Biochem       Date:  1978-12
View more
  10 in total

1.  Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.

Authors:  Carla Martins; Helena Hůlková; Larbi Dridi; Virginie Dormoy-Raclet; Lubov Grigoryeva; Yoo Choi; Alexander Langford-Smith; Fiona L Wilkinson; Kazuhiro Ohmi; Graziella DiCristo; Edith Hamel; Jerôme Ausseil; David Cheillan; Alain Moreau; Eva Svobodová; Zuzana Hájková; Markéta Tesařová; Hana Hansíková; Brian W Bigger; Martin Hrebícek; Alexey V Pshezhetsky
Journal:  Brain       Date:  2015-01-06       Impact factor: 13.501

2.  Sanfilippo A syndrome (mucopolysaccharidosis III A): a neurochemical study.

Authors:  A Federico; J Robert; J P Zanetta; G C Guazzi
Journal:  Ital J Neurol Sci       Date:  1981-05

3.  Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC.

Authors:  Stéphanie Durand; Matthew Feldhammer; Eric Bonneil; Pierre Thibault; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

4.  Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome).

Authors:  Martin Hrebícek; Lenka Mrázová; Volkan Seyrantepe; Stéphanie Durand; Nicole M Roslin; Lenka Nosková; Hana Hartmannová; Robert Ivánek; Alena Cízkova; Helena Poupetová; Jakub Sikora; Jana Urinovská; Viktor Stranecký; Jirí Zeman; Pierre Lepage; David Roquis; Andrei Verner; Jérome Ausseil; Clare E Beesley; Irène Maire; Ben J H M Poorthuis; Jiddeke van de Kamp; Otto P van Diggelen; Ron A Wevers; Thomas J Hudson; T Mary Fujiwara; Jacek Majewski; Kenneth Morgan; Stanislav Kmoch; Alexey V Pshezhetsky
Journal:  Am J Hum Genet       Date:  2006-09-08       Impact factor: 11.025

5.  Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT.

Authors:  Xuefang Pan; Mahsa Taherzadeh; Poulomee Bose; Rachel Heon-Roberts; Annie L A Nguyen; TianMeng Xu; Camila Pará; Yojiro Yamanaka; David A Priestman; Frances M Platt; Shaukat Khan; Nidhi Fnu; Shunji Tomatsu; Carlos R Morales; Alexey V Pshezhetsky
Journal:  J Exp Med       Date:  2022-06-15       Impact factor: 17.579

6.  Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT).

Authors:  Lonneke Haer-Wigman; Hadas Newman; Rina Leibu; Nathalie M Bax; Hagit N Baris; Leah Rizel; Eyal Banin; Amir Massarweh; Susanne Roosing; Dirk J Lefeber; Marijke N Zonneveld-Vrieling; Ofer Isakov; Noam Shomron; Dror Sharon; Anneke I Den Hollander; Carel B Hoyng; Frans P M Cremers; Tamar Ben-Yosef
Journal:  Hum Mol Genet       Date:  2015-04-09       Impact factor: 6.150

7.  Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.

Authors:  Sara Marcó; Anna Pujol; Carles Roca; Sandra Motas; Albert Ribera; Miguel Garcia; Maria Molas; Pilar Villacampa; Cristian S Melia; Víctor Sánchez; Xavier Sánchez; Joan Bertolin; Jesús Ruberte; Virginia Haurigot; Fatima Bosch
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

8.  Protein misfolding as an underlying molecular defect in mucopolysaccharidosis III type C.

Authors:  Matthew Feldhammer; Stéphanie Durand; Alexey V Pshezhetsky
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

Review 9.  Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions.

Authors:  Jeremy Wolfberg; Keerthana Chintalapati; Shunji Tomatsu; Kyoko Nagao
Journal:  Diagnostics (Basel)       Date:  2020-08-04

10.  Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission.

Authors:  Camila Pará; Poulomee Bose; Luigi Bruno; Erika Freemantle; Mahsa Taherzadeh; Xuefang Pan; Chanshuai Han; Peter S McPherson; Jean-Claude Lacaille; Éric Bonneil; Pierre Thibault; Claire O'Leary; Brian Bigger; Carlos Ramon Morales; Graziella Di Cristo; Alexey V Pshezhetsky
Journal:  JCI Insight       Date:  2021-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.